FDA Approved: BELEODAQ — Original Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved Beleodaq (belinostat) from Acrotech Biopharma for relapsed or refractory peripheral T-cell lymphoma, marking an original drug approval for the indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• BELEODAQ (BELINOSTAT)

Snippet

ORIG AP for BELEODAQ (BELINOSTAT)